Digital Discharge Planning to Improve Self-Management in Patients With Diabetes Mellitus
DDP-DM
Effectiveness of a Digital Discharge Planning Intervention to Improve Self-Management in Patients With Diabetes Mellitus: A Randomized Controlled Trial
1 other identifier
interventional
78
1 country
1
Brief Summary
Diabetes mellitus is a chronic disease that requires continuous self-management to prevent complications and hospital readmissions. However, discharge planning in many hospitals is often delivered verbally and lacks structured follow-up after patients return home, which may lead to poor self-management behaviors. This study aims to evaluate the effectiveness of a digital discharge planning intervention delivered through a mobile application to improve self-management among patients with diabetes mellitus after hospital discharge. The intervention is based on the Chronic Care Model and includes educational materials, reminders, and monitoring tools related to seven dimensions of diabetes self-management. A randomized controlled trial with a parallel-group design will be conducted among patients with diabetes mellitus. Participants in the intervention group will receive digital discharge planning through a mobile application for 90 days after discharge, while the control group will receive standard discharge planning provided by the hospital. Primary outcomes include patient self-management behavior, while secondary outcomes include glycemic control and hospital readmission within 90 days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 31, 2026
CompletedFirst Posted
Study publicly available on registry
April 7, 2026
CompletedStudy Start
First participant enrolled
April 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2026
April 13, 2026
April 1, 2026
7 months
March 31, 2026
April 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in diabetes self-management score
Diabetes self-management will be assessed using an adapted Indonesian version of the Summary of Diabetes Self-Care Activities (SDSCA) questionnaire consisting of 21 items across seven domains (healthy eating, physical activity, blood glucose monitoring, medication adherence, problem solving, risk reduction, and healthy coping). Each item is scored on a 5-point Likert scale (1-5) reflecting frequency of behavior during the past 7 days. Total scores range from 21 to 105, with higher scores indicating better diabetes self-management behavior.
Baseline to 90 days after hospital discharge
Secondary Outcomes (2)
Change in HbA1c level
Baseline to 90 days
Hospital readmission within 90 days
Within 90 days after hospital discharge
Study Arms (2)
Digital Discharge Planning
EXPERIMENTALParticipants receive digital discharge planning through a mobile application for 90 days after hospital discharge.
Standard Discharge Planning
ACTIVE COMPARATORParticipants receive standard discharge planning routinely provided by the hospital.
Interventions
A mobile health application designed to support diabetes self-management after hospital discharge, including education, reminders, and monitoring tools for 90 days.
Participants receive standard discharge planning routinely provided by the hospital according to usual care procedures.
Eligibility Criteria
You may qualify if:
- Patients diagnosed with diabetes mellitus.
- Age 18 years or older.
- Hospitalized patients who are preparing for discharge.
- Able to use a smartphone and access the mobile application.
- Willing to participate and provide informed consent.
You may not qualify if:
- Patients with severe complications requiring intensive care.
- Patients with cognitive impairment or severe mental illness that may interfere with participation.
- Patients who are unable to operate a smartphone or mobile application.
- Patients who decline to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
RS Universitas Sebelas Maret
Sukoharjo, Central Java, 57557, Indonesia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- This study uses a single-blind design in which the outcome assessor will be blinded to the group allocation. Participants and investigators will be aware of the intervention due to the nature of the digital discharge planning intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Master's Student, Nursing Science Program
Study Record Dates
First Submitted
March 31, 2026
First Posted
April 7, 2026
Study Start
April 15, 2026
Primary Completion (Estimated)
October 30, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be publicly shared due to privacy and confidentiality considerations. Data may be available from the principal investigator upon reasonable request.